• Quantinuum's IPO is reportedly more than 20 times oversubscribed, signaling intense investor demand for the quantum computing company.
  • The company is considering increasing the issue size and pricing, which could push its valuation to between $14 billion and $14.3 billion, according to people familiar with the matter.
  • Honeywell (HON), which holds a substantial stake, is expected to retain a controlling voting interest post-IPO, while Cambridge Quantum will also maintain a meaningful minority stake.

Oversubscribed IPO Sparks Pricing Talks

Quantinuum, the largest integrated quantum computing company, is seeing its initial public offering more than 20 times oversubscribed, according to sources close to the deal. The strong demand has led to discussions about increasing both the number of shares offered and the price range, potentially lifting the implied valuation to the low-to-mid tens of billions of dollars.

The company plans to offer roughly 26-27 million shares at a price between $53 and $55, aiming to raise up to $1.5 billion before its Nasdaq debut under the ticker QNT. While the exact terms remain under negotiation, the oversubscription highlights a robust appetite for quantum technology as it approaches commercialization.

Government Backing and Strategic Positioning

Adding to investor confidence, Quantinuum has secured U.S. government R&D funding to advance fault-tolerant trapped-ion quantum computing. This policy-level support could accelerate the company's path to market, particularly in applications like drug discovery and cryptography. The company’s revenue for 2025 stands at $30.9 million, with a net loss of $192.6 million, typical for a frontier tech firm investing heavily in growth.

Investor Sentiment and Governance

“The level of interest is off the charts,” said one analyst familiar with the offering, noting that the oversubscription mirrors the enthusiasm for other high-tech IPOs. Honeywell is expected to retain a controlling voting stake after the offering, ensuring long-term strategic alignment. CEO Rajeeb Hazra and Cambridge Quantum founder Ilyas Khan will continue to lead the company.

The IPO is slated for late Q2 2025, subject to market conditions. A spokesperson for Quantinuum declined to comment on the valuation discussions, but noted that the company is focused on executing its growth strategy.